Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
about
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@en
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@nl
type
label
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@en
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@nl
prefLabel
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@en
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@nl
P2860
P356
P1476
Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer.
@en
P2093
P2860
P304
P356
10.21037/TLCR.2017.10.15
P433
P577
2017-12-01T00:00:00Z